Literature DB >> 16467336

Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.

Harry E Prince1, Mary Lapé-Nixon, Jose Matud.   

Abstract

To increase testing efficiency, a microsphere-based multianalyte immune detection (MAID) system was developed to measure serum immunoglobulin G (IgG) and IgA recognizing two Bordetella pertussis antigens, pertussis toxin (PT) and filamentous hemagglutinin antigen (FHA). The assay was performed as two separate duplexes. One duplex measured IgG to PT and FHA, and the other measured IgA to PT and FHA. The two duplexes were then combined and analyzed as a tetraplex. The MAID system and an in-house enzyme-linked immunosorbent assay (ELISA) system were used to evaluate 100 sera from blood donors and 220 consecutive sera submitted for B. pertussis antibody testing. For both the MAID and ELISA systems, antibody levels were defined as increased if greater than the blood donor group 95th percentile value. The qualitative concordance rates between MAID and ELISA results for the 220 consecutively submitted sera were as follows: PT IgG, 99%; PT IgA, 94%; FHA IgG, 93%; FHA IgA, 94%. The overall concordance rate was 95% (836 of 880 result sets). For 29 of 44 (66%) discordant result sets, the discordant MAID result was supported by the MAID and ELISA results for other B. pertussis antibodies. The MAID and in-house ELISA systems were also used to evaluate 20 sera previously tested for pertussis antibodies at a pertussis vaccine research laboratory; MAID results for all four analytes did not significantly differ from results obtained by the research laboratory. These findings show that antibodies to B. pertussis antigens can be measured easily and accurately using a tetraplex microsphere system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16467336      PMCID: PMC1391947          DOI: 10.1128/CVI.13.2.266-270.2006

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  16 in total

1.  Serologic response and antibody-titer decay in adults with pertussis.

Authors:  Ulrich Heininger; James D Cherry; Klemens Stehr
Journal:  Clin Infect Dis       Date:  2004-01-29       Impact factor: 9.079

2.  Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study.

Authors:  Thuan Le; James D Cherry; Swei-Ju Chang; Maria Deloria Knoll; Martin L Lee; Steve Barenkamp; David Bernstein; Robert Edelman; Kathryn M Edwards; David Greenberg; Wendy Keitel; John Treanor; Joel I Ward
Journal:  J Infect Dis       Date:  2004-07-07       Impact factor: 5.226

3.  Evaluation of culture, immunofluorescence, and serology for the diagnosis of pertussis.

Authors:  S A Halperin; R Bortolussi; A J Wort
Journal:  J Clin Microbiol       Date:  1989-04       Impact factor: 5.948

4.  Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines.

Authors:  B D Meade; A Deforest; K M Edwards; T A Romani; F Lynn; C H O'Brien; C B Swartz; G F Reed; M A Deloria
Journal:  Pediatrics       Date:  1995-09       Impact factor: 7.124

5.  Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis.

Authors:  J Isacson; B Trollfors; J Taranger; T Lagergård
Journal:  Pediatr Infect Dis J       Date:  1995-06       Impact factor: 2.129

6.  Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents.

Authors:  S L Hodder; J D Cherry; E A Mortimer; A B Ford; J Gornbein; K Papp
Journal:  Clin Infect Dis       Date:  2000-07-24       Impact factor: 9.079

7.  New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative.

Authors:  Kevin D Forsyth; Magda Campins-Marti; Jaime Caro; James D Cherry; David Greenberg; Nicole Guiso; Ulrich Heininger; Joop Schellekens; Tina Tan; Carl-Heinz Wirsing von König; Stanley Plotkin
Journal:  Clin Infect Dis       Date:  2004-11-18       Impact factor: 9.079

8.  Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness.

Authors:  C D Marchant; A M Loughlin; S M Lett; C W Todd; L H Wetterlow; R Bicchieri; S Higham; P Etkind; E Silva; G R Siber
Journal:  J Infect Dis       Date:  1994-06       Impact factor: 5.226

9.  Frequency of unrecognized Bordetella pertussis infections in adults.

Authors:  J G Deville; J D Cherry; P D Christenson; E Pineda; C T Leach; T L Kuhls; S Viker
Journal:  Clin Infect Dis       Date:  1995-09       Impact factor: 9.079

10.  Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins.

Authors:  Raymond E Biagini; Deborah L Sammons; Jerome P Smith; Barbara A MacKenzie; Cynthia A F Striley; Vera Semenova; Evelen Steward-Clark; Karen Stamey; Alison E Freeman; Conrad P Quinn; John E Snawder
Journal:  Clin Diagn Lab Immunol       Date:  2004-01
View more
  16 in total

1.  Measuring immunoglobulin g antibodies to tetanus toxin, diphtheria toxin, and pertussis toxin with single-antigen enzyme-linked immunosorbent assays and a bead-based multiplex assay.

Authors:  Sabine Reder; Marion Riffelmann; Christian Becker; Carl Heinz Wirsing von König
Journal:  Clin Vaccine Immunol       Date:  2008-03-05

2.  Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay.

Authors:  Richarda M de Voer; Rutger M Schepp; Florens G A Versteegh; Fiona R M van der Klis; Guy A M Berbers
Journal:  Clin Vaccine Immunol       Date:  2009-01-07

3.  Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides.

Authors:  Richarda M de Voer; Fiona R M van der Klis; Carla W A M Engels; Ger T Rijkers; Elisabeth A Sanders; Guy A M Berbers
Journal:  Clin Vaccine Immunol       Date:  2008-06-11

4.  Elimination of false-positive results in a luminex assay for pneumococcal antibodies.

Authors:  Jerry W Pickering; Matthew T Larson; Thomas B Martins; Susan S Copple; Harry R Hill
Journal:  Clin Vaccine Immunol       Date:  2009-11-18

5.  Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection.

Authors:  Sandra L Menzies; Vijay Kadwad; Lucia C Pawloski; Tsai-Lien Lin; Andrew L Baughman; Monte Martin; Maria Lucia C Tondella; Bruce D Meade
Journal:  Clin Vaccine Immunol       Date:  2009-10-28

6.  Antibody levels to Bordetella pertussis and Neisseria meningitidis in immunodeficient patients receiving immunoglobulin replacement therapy.

Authors:  Etai Adam; Joseph A Church
Journal:  J Clin Immunol       Date:  2015-01-29       Impact factor: 8.317

7.  Fast, antigen-saving multiplex immunoassay to determine levels and avidity of mouse serum antibodies to pertussis, diphtheria, and tetanus antigens.

Authors:  Rachel M Stenger; Mieke Smits; Betsy Kuipers; Sabine F M Kessen; Claire J P Boog; Cécile A C M van Els
Journal:  Clin Vaccine Immunol       Date:  2011-02-16

8.  Age-related differences in patterns of increased Bordetella pertussis antibodies.

Authors:  Harry E Prince; Jay M Lieberman; James D Cherry
Journal:  Clin Vaccine Immunol       Date:  2012-02-22

9.  Serologic assay to quantify human immunoglobulin G antibodies to the Staphylococcus aureus iron surface determinant B antigen.

Authors:  Michael D Raedler; Samantha Heyne; Erica Wagner; Sheri K Shalkowski; Susan Secore; Annaliesa S Anderson; James Cook; Leslie Cope; Tessie McNeely; Mary Retzlaff; Jon Shanter; Leonard J Rubinstein; Tina Green; N Kartsonis; Mark T Esser
Journal:  Clin Vaccine Immunol       Date:  2009-03-25

10.  Development and validation of a robust multiplex serological assay to quantify antibodies specific to pertussis antigens.

Authors:  Gowrisankar Rajam; George Carlone; Ellie Kim; Jin Choi; Simon Paulos; SoHee Park; Amilia Jeyachandran; Yamini Gorantla; Emily Wong; Amit Sabnis; Peter Browning; Rita Desai; Conrad P Quinn; Jarad Schiffer
Journal:  Biologicals       Date:  2018-11-18       Impact factor: 1.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.